1 The Third Clinical Medical School, Zhejiang Chinese Medicine University, Hangzhou, China 2 Institute of International Education of Zhejiang Chinese Medical University, Hangzhou, China Background: ...
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study.
For SUI and pain associated with diabetic peripheral neuropathy, duloxetine has not demonstrated equivalence or superiority to existing therapies. The adverse effects of duloxetine are similar to ...
Methods: Patients having an identifiable cause of peripheral neuropathy, except alcohol, were excluded from the study. Patients with evidence of vitamin B 12 deficiency or diabetes were also ...
A year-long integrated, intensive action plan is being chalked out to augment all diabetes control programmes in the State. The programme, which will be kicked off on November 14, World Diabetes Day, ...